Dr. Deepa Taneja, MD
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
- Medicare participating
At a glance
- Years since graduation
- 32
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 213
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
FL license ME108647
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Adventhealth Orlando Orlando, FL
- Orlando Health Orlando, FL
- Orlando Health-Health Central Hospital Ocoee, FL
- Adventhealth Heart of Florida Davenport, FL
Medical groups
- Florida Diabetes Thyroid and Endocrine Center Pl (3 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 213
- Services billed
- 868
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 337 | 151 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 159 | 64 |
| Established patient office or other outpatient visit, 20-29 minutes | 112 | 74 |
| Established patient office or other outpatient visit, 40-54 minutes | 86 | 52 |
| New patient office or other outpatient visit, 45-59 minutes | 42 | 42 |
| Ultrasound scan of head and neck soft tissue | 32 | 29 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 32 | 30 |
| Ultrasonic guidance for needle placement | 14 | 14 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 14 | 14 |
| New patient office or other outpatient visit, 30-44 minutes | 13 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levothyroxine Sodium Other prescribers in Orlando, FL | 406 |
| Rosuvastatin Calcium Other prescribers in Orlando, FL | 339 |
| Ozempic (semaglutide) Other prescribers in Orlando, FL | 253 |
| Omnipod Dash Pods (Gen 4) (insulin pump cart,cont inf,bt) | 221 |
| Metformin Hcl Er (metformin hcl) Other prescribers in Orlando, FL | 221 |
| Nateglinide | 208 |
| Ezetimibe Other prescribers in Orlando, FL | 161 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) (insulin pump cart,auto,bt,g6/7) | 152 |
| Losartan Potassium Other prescribers in Orlando, FL | 128 |
| Repatha Sureclick (evolocumab) Other prescribers in Orlando, FL | 123 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 28 companies reported 106 payments worth $5,253 in total to this clinician.
| Sanofi-aventis U.S. LLC | $2,896 |
|---|---|
| Insulet Corporation | $313 |
| Amgen Inc. | $265 |
| Novo Nordisk Inc | $248 |
| Ascendis Pharma Endocrinology Inc | $214 |
| Alexion Pharmaceuticals, Inc. | $168 |
| Recordati_rare_diseases_inc. | $156 |
| Esperion Therapeutics, Inc. | $88.20 |
| Food and Beverage | $2,711 |
|---|---|
| Consulting Fee | $2,543 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Sanofi-aventis U.S. LLC Sep 30, 2025 | Consulting Fee | $2,543 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.